Viewing Study NCT01050218

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 4:58 AM

Ignite Modification Date: 2025-12-26 @ 3:58 AM

Study NCT ID: NCT01050218

Status: TERMINATED

Last Update Posted: 2023-12-11

First Post: 2010-01-13

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Study Evaluating the Long-Term Safety of Desvenlafaxine Succinate Sustained-Release (DVS SR) in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module